Vir Biotechnology Inc (VIR)
9.69
-0.04
(-0.41%)
USD |
NASDAQ |
May 20, 16:00
9.70
+0.01
(+0.10%)
After-Hours: 20:00
Vir Biotechnology Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -104.81M |
| September 30, 2023 | -58.95M |
| June 30, 2023 | 230.32M |
| March 31, 2023 | 98.08M |
| December 31, 2022 | -153.14M |
| September 30, 2022 | -662.60M |
| June 30, 2022 | -272.33M |
| March 31, 2022 | -105.39M |
| December 31, 2021 | -377.58M |
| September 30, 2021 | 73.86M |
| Date | Value |
|---|---|
| June 30, 2021 | 75.38M |
| March 31, 2021 | 87.53M |
| December 31, 2020 | 60.71M |
| September 30, 2020 | -185.38M |
| June 30, 2020 | 10.58M |
| March 31, 2020 | 104.22M |
| December 31, 2019 | -73.77M |
| September 30, 2019 | 47.29M |
| June 30, 2019 | 44.48M |
| March 31, 2019 | -274.16M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-662.60M
Minimum
Sep 2022
230.32M
Maximum
Jun 2023
-61.13M
Average
10.58M
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | -2.136B |
| SeaStar Medical Holding Corp | -- |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 1.00M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -800.36M |
| Free Cash Flow Per Share (Quarterly) | -0.8132 |
| Free Cash Flow to Equity (Quarterly) | -109.46M |
| Free Cash Flow to Firm (Quarterly) | -109.46M |
| Free Cash Flow Yield | -61.38% |